Very late-onset membranous nephropathy secondary to alemtuzumab in a patient with multiple sclerosis

Introduction Multiple sclerosis (MS) is a chronic multifocal inflammatory demyelinating disease that progresses with neurodegeneration and is associated with a high risk of disability. Objectives We describe a series of patients diagnosed with MS in […]

Introduction This paper highlights the relationship of inflammation and oxidative stress as damage mechanisms of Multiple Sclerosis (MS), considered an inflammatory and autoimmune disease. Development The oxidative stress concept has been defined by an imbalance […]

Los fármacos modificadores de la esclerosis múltiple (FAME) han supuesto un cambio en el manejo de esta enfermedad. Algunos estudios sugieren un incremento en la incidencia de cáncer cutáneo (CC) asociado a estos medicamentos. Mediante […]